Canada Markets closed

OrganiGram Holdings Inc. (OGI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.4400-0.0800 (-5.26%)
At close: 04:00PM EST
1.4200 -0.02 (-1.39%)
After hours: 07:48PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close1.5200
Open1.5100
Bid1.4300 x 21500
Ask1.4400 x 40700
Day's Range1.4200 - 1.5199
52 Week Range1.4200 - 6.4500
Volume6,821,968
Avg. Volume7,649,693
Market Cap450.841M
Beta (5Y Monthly)1.15
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • Business Wire

    Organigram Reports First Quarter Fiscal 2022 Results

    MONCTON, New Brunswick, January 11, 2022--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, announced its results for the first quarter ended November 30, 2021 ("Q1 Fiscal 2022").

  • Business Wire

    Organigram to Report First Quarter Fiscal 2022 Results on January 11, 2022

    MONCTON, New Brunswick, January 05, 2022--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2022 ended November 30, 2021 on Tuesday, January 11, 2022 before market open.

  • Business Wire

    Organigram Makes Additional $2.5 Million Investment in Hyasynth Biologicals, a Leading Cannabinoid Biosynthesis Company

    MONCTON, New Brunswick, December 22, 2021--As an early investor in biosynthesis, Organigram Holdings Inc. (NASDAQ: OGI), (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, and Hyasynth Biologicals Inc. ("Hyasynth") a private biotechnology company and pioneer in the field of cannabinoid science and biosynthesis are pleased to announce that Organigram has acquired an additional $2.5 million of secured convertible debentures i